* JPM PACIFIC EQUITY D (ACC) EUR | 30/09 | 21,11% |
| * JPM PACIFIC EQUITY D (ACC) USD | 30/09 | 21,34% |
| ** JPM PACIFIC EQUITY I2 (ACC) EUR | 30/09 | 22,83% |
| ** JPM PACIFIC EQUITY I2 (ACC) USD | 30/09 | 23,06% |
| ** JPM PACIFIC EQUITY I (ACC) USD | 30/09 | 22,79% |
| * JPM SGD LIQUIDITY LVNAV AGENCY (DIST) | 30/09 | 4,15% |
| *** JPM SGD LIQUIDITY LVNAV C (ACC) | 30/09 | 4,99% |
| * JPM SGD LIQUIDITY LVNAV C (DIST) | 30/09 | 4,15% |
| ND JPM SGD LIQUIDITY LVNAV CORE (DIST) | 30/09 | 4,15% |
| *** JPM SGD LIQUIDITY LVNAV E (ACC) | 30/09 | 5,08% |
| * JPM SGD LIQUIDITY LVNAV E (DIST) | 30/09 | 4,15% |
| * JPM SGD LIQUIDITY LVNAV INSTITUTIONAL (DIST) | 30/09 | 4,15% |
| ***** JPM TAIWAN A (ACC) EUR | 30/09 | 86,22% |
| ***** JPM TAIWAN A (ACC) USD | 30/09 | 86,58% |
| ***** JPM TAIWAN A (DIST) USD | 30/09 | 86,47% |
| ***** JPM TAIWAN C (ACC) USD | 30/09 | 87,77% |
| ***** JPM TAIWAN C (DIST) USD | 30/09 | 86,64% |
| ***** JPM TAIWAN D (ACC) USD | 30/09 | 85,19% |
| ***** JPM TAIWAN I (ACC) EUR | 30/09 | 87,46% |
| ***** JPM TAIWAN I (ACC) USD | 30/09 | 87,81% |
| ** JPM THEMATICS-GENETIC THERAPIES A (ACC) CHF (HEDGED) | 30/09 | 15,94% |
| ** JPM THEMATICS-GENETIC THERAPIES A (ACC) EUR (HEDGED) | 30/09 | 19,80% |
| ** JPM THEMATICS-GENETIC THERAPIES A (ACC) USD | 30/09 | 24,48% |
| ** JPM THEMATICS-GENETIC THERAPIES A (DIST) CHF (HEDGED) | 30/09 | 15,94% |
| ** JPM THEMATICS-GENETIC THERAPIES A (DIST) EUR (HEDGED) | 30/09 | 19,77% |
| ** JPM THEMATICS-GENETIC THERAPIES A (DIST) USD | 30/09 | 24,43% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (ACC) CHF (HEDGED) | 30/09 | 16,45% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | 30/09 | 20,29% |
| *** JPM THEMATICS-GENETIC THERAPIES C2 (ACC) GBP (HEDGED) | 30/09 | 24,29% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (ACC) USD | 30/09 | 24,98% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (DIST) CHF (HEDGED) | 30/09 | 16,06% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (DIST) EUR (HEDGED) | 30/09 | 19,91% |
| *** JPM THEMATICS-GENETIC THERAPIES C2 (DIST) GBP (HEDGED) | 30/09 | 23,84% |
| ** JPM THEMATICS-GENETIC THERAPIES C2 (DIST) USD | 30/09 | 24,59% |
| ** JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | 30/09 | 20,17% |
| ** JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | 30/09 | 24,87% |
| ** JPM THEMATICS-GENETIC THERAPIES C (DIST) GBP | 30/09 | 24,43% |
| ** JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | 30/09 | 24,60% |
| ** JPM THEMATICS-GENETIC THERAPIES D (ACC) EUR (HEDGED) | 30/09 | 18,92% |
| ** JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | 30/09 | 23,52% |
| ** JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | 30/09 | 20,32% |
| ** JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | 30/09 | 25,01% |
| ** JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | 30/09 | 24,68% |
| ** JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | 30/09 | 20,23% |
| ***** JPM TOTAL EMERGING MARKETS INCOME A (ACC) EUR | 30/09 | 15,65% |
| ***** JPM TOTAL EMERGING MARKETS INCOME A (ACC) USD | 30/09 | 15,86% |
| ** JPM TOTAL EMERGING MARKETS INCOME A (DIST) EUR | 30/09 | 12,90% |
| * JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | 30/09 | 10,90% |
| ***** JPM TOTAL EMERGING MARKETS INCOME C (ACC) EUR | 30/09 | 16,30% |
| **** JPM TOTAL EMERGING MARKETS INCOME D (ACC) EUR | 30/09 | 15,08% |
